Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study
- PMID: 23610117
- DOI: 10.1200/JCO.2012.45.6335
Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study
Abstract
Purpose: We aimed to determine the prognosis of patients with breast cancer diagnosed during pregnancy (BCP).
Patients and methods: In this cohort study, a multicentric registry of patients with BCP (from Cancer in Pregnancy, Leuven, Belgium, and GBG 29/BIG 02-03) compiled pro- and retrospectively between 2003 and 2011 was compared with patients who did not have associated pregnancies, using an age limit of 45 years. Patients with a diagnosis postpartum were excluded. The main analysis was performed using Cox proportional hazards regression of disease-free survival (DFS) and overall survival (OS) on exposure (pregnant or not), adjusting for age, stage, grade, hormone receptor status, human epidermal growth factor 2 status, histology, type of chemotherapy, use of trastuzumab, radiotherapy, and hormone therapy.
Results: The registry contained 447 women with BCP, mainly originating from Germany and Belgium, of whom 311 (69.6%) were eligible for analysis. The nonpregnant group consisted of 865 women. Median age was 33 years for the pregnant and 41 years for the nonpregnant patients. Median follow-up was 61 months. The hazard ratio of pregnancy was 1.34 (95% CI, 0.93 to 1.91; P = .14) for DFS and 1.19 (95% CI, 0.73 to 1.93; P = .51) for OS. Cox regression estimated that the 5-year DFS rate for pregnant patients would have increased from 65% to 71% if these patients had not been pregnant. Likewise, the 5-year OS rate would have increased from 78% to 81%.
Conclusion: The results show similar OS for patients diagnosed with BCP compared with nonpregnant patients. This information is important when patients are counseled and supports the option to start treatment with continuation of pregnancy.
Comment in
-
Pregnancy during or after breast cancer diagnosis: what do we know and what do we need to know?J Clin Oncol. 2013 Jul 10;31(20):2521-2. doi: 10.1200/JCO.2013.49.7347. Epub 2013 Jun 3. J Clin Oncol. 2013. PMID: 23733755 No abstract available.
-
[Prognosis of pregnant women with primary breast cancer].Strahlenther Onkol. 2013 Nov;189(11):980-1. doi: 10.1007/s00066-013-0455-6. Strahlenther Onkol. 2013. PMID: 24158605 German. No abstract available.
-
Reply to D. Crivellari et al.J Clin Oncol. 2014 Jan 20;32(3):255-6. doi: 10.1200/JCO.2013.53.1012. Epub 2013 Dec 2. J Clin Oncol. 2014. PMID: 24297941 No abstract available.
-
Prognosis of women with primary breast cancer diagnosed during pregnancy.J Clin Oncol. 2014 Jan 20;32(3):255. doi: 10.1200/JCO.2013.52.3977. Epub 2013 Dec 2. J Clin Oncol. 2014. PMID: 24297947 No abstract available.
Similar articles
-
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French study.Eur J Cancer. 2018 May;95:30-37. doi: 10.1016/j.ejca.2018.02.030. Epub 2018 Apr 3. Eur J Cancer. 2018. PMID: 29625257
-
Survival outcomes in pregnancy associated breast cancer: a retrospective case control study.Breast J. 2012 Mar-Apr;18(2):139-44. doi: 10.1111/j.1524-4741.2011.01201.x. Epub 2012 Feb 23. Breast J. 2012. PMID: 22356297
-
The biological features and prognosis of breast cancer diagnosed during pregnancy: a case-control study.Acta Oncol. 2012 May;51(5):653-61. doi: 10.3109/0284186X.2011.636069. Epub 2011 Dec 16. Acta Oncol. 2012. PMID: 22171586
-
Breast cancer during pregnancy: a literature review.Minerva Ginecol. 2010 Dec;62(6):585-97. Minerva Ginecol. 2010. PMID: 21079579 Review.
-
Pregnancy-associated breast cancer.Semin Surg Oncol. 1991 Sep-Oct;7(5):306-10. doi: 10.1002/ssu.2980070514. Semin Surg Oncol. 1991. PMID: 1775817 Review.
Cited by
-
Trastuzumab administration during pregnancy: an update.BMC Cancer. 2021 Apr 26;21(1):463. doi: 10.1186/s12885-021-08162-3. BMC Cancer. 2021. PMID: 33902516 Free PMC article.
-
CAnceR IN PreGnancy (CARING) - a retrospective study of cancer diagnosed during pregnancy in the United Kingdom.Br J Cancer. 2024 May;130(8):1261-1268. doi: 10.1038/s41416-024-02605-x. Epub 2024 Feb 21. Br J Cancer. 2024. PMID: 38383704 Free PMC article.
-
Cancer during Pregnancy: A Review of Preclinical and Clinical Transplacental Transfer of Anticancer Agents.Cancers (Basel). 2021 Mar 11;13(6):1238. doi: 10.3390/cancers13061238. Cancers (Basel). 2021. PMID: 33799824 Free PMC article. Review.
-
Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer.NPJ Breast Cancer. 2020 Oct 19;6:56. doi: 10.1038/s41523-020-00198-1. eCollection 2020. NPJ Breast Cancer. 2020. PMID: 33088913 Free PMC article.
-
Surgical and obstetric outcomes of breast cancer surgery during pregnancy: a nationwide database study in Japan.Breast Cancer Res Treat. 2022 Oct;195(3):289-299. doi: 10.1007/s10549-022-06659-4. Epub 2022 Aug 2. Breast Cancer Res Treat. 2022. PMID: 35917051
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical